RSV vaccine approved for use in at-risk over-50s The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.
‘Get asymptomatic testing’: STI test push amid rising cases Testing rates continue to stagnate despite the spike, leaving some to question whether GPs are comfortable discussing the topic.
In Practice: Face-to-face opportunities for rural members RACGP Rural is inviting members to join upcoming face-to-face events for networking and educational opportunities.
New STI awareness campaign launches The campaign, which is targeting young people, is looking to encourage safe sex and regular testing.
Grant program opens to develop silicosis training Proposals are being sought for the training of healthcare professionals to help the diagnosis and treatment of dust diseases.
First RSV vaccine approved in US The US drugs regulator has given the green light to a new vaccine, which is also under consideration by the TGA in Australia.
Warning over Japanese encephalitis numbers As the wet weather continues, infectious disease experts have suggested almost 750,000 people could be at risk from the mosquito-borne virus.
Studies focus on COVID infectious period Early research suggests a quarter of people or more may still be infectious with COVID-19 after seven days, the standard isolation period across Australia.
WHO gives warning on missed measles vaccinations Measles vaccination has fallen sharply globally, but Australian immunisation rates appear to have held up despite the challenges of COVID-19.
Ongoing epidemic remains among world’s deadliest GP Dr Janice Tan explains how an ‘ancient disease’ mostly found thousands of kilometres away still impacts Australia.